These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15486497)

  • 1. Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences.
    Le Foll B; Goldberg SR
    Neuroreport; 2004 Sep; 15(13):2139-43. PubMed ID: 15486497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).
    Cohen C; Perrault G; Griebel G; Soubrié P
    Neuropsychopharmacology; 2005 Jan; 30(1):145-55. PubMed ID: 15292905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid CB1 receptor antagonist rimonabant disrupts nicotine reward-associated memory in rats.
    Fang Q; Li FQ; Li YQ; Xue YX; He YY; Liu JF; Lu L; Wang JS
    Pharmacol Biochem Behav; 2011 Oct; 99(4):738-42. PubMed ID: 21722663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats.
    Cohen C; Perrault G; Voltz C; Steinberg R; Soubrié P
    Behav Pharmacol; 2002 Sep; 13(5-6):451-63. PubMed ID: 12394421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
    Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B
    Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats.
    Shoaib M
    Neuropharmacology; 2008 Feb; 54(2):438-44. PubMed ID: 18054052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basolateral amygdala CB1 cannabinoid receptors mediate nicotine-induced place preference.
    Hashemizadeh S; Sardari M; Rezayof A
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():65-71. PubMed ID: 24468643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
    Schindler CW; Redhi GH; Vemuri K; Makriyannis A; Le Foll B; Bergman J; Goldberg SR; Justinova Z
    Neuropsychopharmacology; 2016 Aug; 41(9):2283-93. PubMed ID: 26888056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats.
    Forget B; Hamon M; Thiébot MH
    Psychopharmacology (Berl); 2005 Oct; 181(4):722-34. PubMed ID: 15986197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of conditioned nicotine and sucrose seeking by the cannabinoid-1 receptor antagonist SR141716A.
    De Vries TJ; de Vries W; Janssen MC; Schoffelmeer AN
    Behav Brain Res; 2005 Jun; 161(1):164-8. PubMed ID: 15904723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.
    Xi ZX; Spiller K; Pak AC; Gilbert J; Dillon C; Li X; Peng XQ; Gardner EL
    Neuropsychopharmacology; 2008 Jun; 33(7):1735-45. PubMed ID: 17728698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats.
    Forget B; Barthélémy S; Saurini F; Hamon M; Thiébot MH
    Psychopharmacology (Berl); 2006 Nov; 189(1):59-69. PubMed ID: 16969683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The disruptive effects of the CB1 receptor antagonist rimonabant on extinction learning in mice are task-specific.
    Niyuhire F; Varvel SA; Thorpe AJ; Stokes RJ; Wiley JL; Lichtman AH
    Psychopharmacology (Berl); 2007 Apr; 191(2):223-31. PubMed ID: 17211653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rimonabant attenuates sensitization, cross-sensitization and cross-reinstatement of place preference induced by nicotine and ethanol.
    Biała G; Budzyńska B
    Pharmacol Rep; 2010; 62(5):797-807. PubMed ID: 21098863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CB1 antagonist rimonabant (SR141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse.
    Ward SJ; Rosenberg M; Dykstra LA; Walker EA
    Drug Alcohol Depend; 2009 Dec; 105(3):248-55. PubMed ID: 19679410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
    Gueye AB; Pryslawsky Y; Trigo JM; Poulia N; Delis F; Antoniou K; Loureiro M; Laviolette SR; Vemuri K; Makriyannis A; Le Foll B
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27493155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol.
    López-Moreno JA; González-Cuevas G; Navarro M
    Neurobiol Dis; 2007 Feb; 25(2):274-83. PubMed ID: 17067804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of SR141716 on post-reinforcement pauses in operant responding for sucrose reward in rats.
    Pério A; Barnouin MC; Poncelet M; Soubrié P
    Behav Pharmacol; 2001 Dec; 12(8):641-5. PubMed ID: 11856902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of baclofen on conditioned rewarding and discriminative stimulus effects of nicotine in rats.
    Le Foll B; Wertheim CE; Goldberg SR
    Neurosci Lett; 2008 Oct; 443(3):236-40. PubMed ID: 18682277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid CB(1) receptor antagonist rimonabant attenuates reinstatement of ketamine conditioned place preference in rats.
    Li F; Fang Q; Liu Y; Zhao M; Li D; Wang J; Lu L
    Eur J Pharmacol; 2008 Jul; 589(1-3):122-6. PubMed ID: 18534572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.